Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Bioorganic & Medicinal Chemistry
|
May 3, 2005
Investigation into the structure-activity relationship of novel concentration dependent, dual action T-type calcium channel agonists/antagonists
William F McCalmont, Jaclyn R Patterson, Michael A Lindenmuth, et al.
The Journal of Biological Chemistry
|
January 24, 2007
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor
Myat Lin Oo, Shobha Thangada, Ming-Tao Wu, et al.
Journal of the American College of Cardiology
|
November 13, 2002
Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation
Laurent M Riou, Mirta Ruiz, Jayson M Rieger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 3, 2011
Characterization of a sphingosine 1-phosphate receptor antagonist prodrug
Perry C Kennedy, Ran Zhu, Tao Huang, et al.
The Biochemical Journal
|
August 19, 2011
Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate
Yugesh Kharel, Thomas P Mathews, Amanda M Gellett, et al.
ACS Medicinal Chemistry Letters
|
May 19, 2016
Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles
Joseph D Houck, Thomas K Dawson, Andrew J Kennedy, et al.
Bioorganic & Medicinal Chemistry
|
July 28, 2009
Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs
Frank W Foss, Thomas P Mathews, Yugesh Kharel, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
February 20, 2007
Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia
David K Glover, Mirta Ruiz, Kazuya Takehana, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 14, 2004
Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium
David K Glover, Laurent M Riou, Mirta Ruiz, et al.
Journal of Medicinal Chemistry
|
April 19, 2011
Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells
Andrew J Kennedy, Thomas P Mathews, Yugesh Kharel, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Bioorganic & Medicinal Chemistry
|
May 3, 2005
Investigation into the structure-activity relationship of novel concentration dependent, dual action T-type calcium channel agonists/antagonists
William F McCalmont, Jaclyn R Patterson, Michael A Lindenmuth, et al.
The Journal of Biological Chemistry
|
January 24, 2007
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor
Myat Lin Oo, Shobha Thangada, Ming-Tao Wu, et al.
Journal of the American College of Cardiology
|
November 13, 2002
Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation
Laurent M Riou, Mirta Ruiz, Jayson M Rieger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 3, 2011
Characterization of a sphingosine 1-phosphate receptor antagonist prodrug
Perry C Kennedy, Ran Zhu, Tao Huang, et al.
The Biochemical Journal
|
August 19, 2011
Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate
Yugesh Kharel, Thomas P Mathews, Amanda M Gellett, et al.
ACS Medicinal Chemistry Letters
|
May 19, 2016
Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles
Joseph D Houck, Thomas K Dawson, Andrew J Kennedy, et al.
Bioorganic & Medicinal Chemistry
|
July 28, 2009
Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs
Frank W Foss, Thomas P Mathews, Yugesh Kharel, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
February 20, 2007
Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia
David K Glover, Mirta Ruiz, Kazuya Takehana, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 14, 2004
Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium
David K Glover, Laurent M Riou, Mirta Ruiz, et al.
Journal of Medicinal Chemistry
|
April 19, 2011
Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells
Andrew J Kennedy, Thomas P Mathews, Yugesh Kharel, et al.
Page
of 8